申请人:Merck Patent Gesellschaft Mit Beschrankter Haftung
公开号:US05747539A1
公开(公告)日:1998-05-05
Fluorine-containing benzoylguanidines of the formula I ##STR1## in which R.sup.1, R.sup.2 and R.sup.3 have the meanings indicated, and their physiologically acceptable salts, have antiarrhythmic properties and act as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter, for example.
公式I中含氟苯甲酰胍,其中R.sup.1,R.sup.2和R.sup.3具有所示的含义,并且它们的生理上可接受的盐具有抗心律失常性能并作为细胞Na.sup.+ / H.sup.+抗运输体的抑制剂。